SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (766)1/1/1998 10:45:00 PM
From: pmarz   of 1115
 
Its really plain and simple, if Lidak is not hiding bad placebo numbers this stock is going up tomorrow, if they are , they are finished, and I do mean finished. This is a non event to a positive if BMY cancelled the agreement for other reasons than Lidakol not working. I have been in this stock since the IPO and this is the 2nd time a marketing agreement has been cancelled. The first one , I think was Roche in 1992.(not sure) The stock hit 50 cents the next day , and closed at about a $1.00, then it ran to ten in the next 8 months. Im certainly hoping Katz is not hiding anything, tax write off if he is.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News